Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Revenue

Ajooni Biotech had revenue of 619.26M INR in the quarter ending March 31, 2026, with 103.35% growth. This brings the company's revenue in the last twelve months to 1.53B, up 45.13% year-over-year. In the fiscal year ending March 31, 2025, Ajooni Biotech had annual revenue of 1.16B with 44.38% growth.

• Revenue (ttm): 1.53B
• Revenue Growth: +45.13%
• P/S Ratio: 0.36
• Revenue / Employee: 13.79M
• Employees: 134
• Market Cap: 659.69M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.16B	356.18M	44.38%
Mar 31, 2024	802.54M	57.66M	7.74%
Mar 31, 2023	744.88M	4.50M	0.61%
Mar 31, 2022	740.38M	229.99M	45.06%
Mar 31, 2021	510.39M	110.06M	27.49%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error